Clinical Trial Update: Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not

View source ↗

Summary

A completed study evaluated the risk of coronary heart disease and heart failure in prostate cancer patients treated with Casodex (bicalutamide) versus not trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Heart Failure
• Prostate Cancer

Drugs mentioned

• Casodex (bicalutamide)

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer | Status: COMPLETED